Actos and Bladder Cancer Risks Lawsuit Attorney Florida.
Recent research suggests that Actos side effects are a potential concern for diabetes patients with regards to bladder cancer. These concerns about the potential risk from Actos first surfaced after discovery that rats given the drug had a higher rate of bladder tumors. Recent results from an ongoing 10-year study, involving nearly 200,000 patients with diabetes, suggest that there may be an increased risk of bladder cancer from Actos the longer the medication is taken. In September of 2010, the FDA announced that Takeda Pharmaceuticals, the type 2 diabetes drug’s manufacturer, provided interim data after five years that suggests there may be a risk of bladder cancer from Actos side effects associated with prolonged use of the medication. The rate of exposure and the increased Actos cancer risk reached statistical significance after 24 months of use. In June of 2011, a recall of Actos was issued in France after health authorities ordered doctors to stop prescribing the drug due to the possible risk of bladder cancer, and a French study of public insurance data confirmed that there is a slight increase in the risk of bladder cancer with the use of the medication, adding to the prior concerns about its long-term use.